tiprankstipranks
Trending News
More News >
Bastide le Confort Medical SA (GB:0IP1)
LSE:0IP1
UK Market

Bastide le Confort Medical (0IP1) Ratios

Compare
0 Followers

Bastide le Confort Medical Ratios

GB:0IP1's free cash flow for Q2 2025 was €0.10. For the 2025 fiscal year, GB:0IP1's free cash flow was decreased by € and operating cash flow was €0.09. See a summary of the company’s cash flow.
Ratios
TTM
Jun 24Jun 23Jun 22Jun 21
Liquidity Ratios
Current Ratio
0.97 0.87 1.07 1.11 1.20
Quick Ratio
0.69 0.60 0.72 0.72 0.75
Cash Ratio
0.11 0.16 0.13 0.23 0.25
Solvency Ratio
0.11 0.13 0.13 0.13 0.14
Operating Cash Flow Ratio
0.31 0.40 0.27 0.45 0.28
Short-Term Operating Cash Flow Coverage
1.38 1.19 1.19 3.84 2.69
Net Current Asset Value
€ -357.42M€ -372.58M€ -359.25M€ -319.92M€ -254.49M
Leverage Ratios
Debt-to-Assets Ratio
0.63 0.65 0.66 0.63 0.61
Debt-to-Equity Ratio
5.12 4.88 4.96 4.40 4.05
Debt-to-Capital Ratio
0.84 0.83 0.83 0.81 0.80
Long-Term Debt-to-Capital Ratio
0.78 0.76 0.78 0.76 0.75
Financial Leverage Ratio
8.11 7.50 7.48 7.00 6.69
Debt Service Coverage Ratio
1.33 0.83 1.42 2.81 2.34
Interest Coverage Ratio
1.62 2.58 3.05 4.07 3.21
Debt to Market Cap
2.37 1.55 1.30 0.78 0.97
Interest Debt Per Share
58.44 55.93 58.79 49.93 43.28
Net Debt to EBITDA
3.59 4.74 4.99 4.04 4.06
Profitability Margins
Gross Profit Margin
8.84%65.69%65.51%63.11%65.74%
EBIT Margin
8.28%8.43%8.31%6.55%8.80%
EBITDA Margin
20.24%16.21%16.98%18.06%17.42%
Operating Profit Margin
8.35%8.43%8.31%8.45%8.80%
Pretax Profit Margin
3.12%4.48%4.49%4.54%5.30%
Net Profit Margin
-0.17%3.16%2.92%3.03%3.03%
Continuous Operations Profit Margin
1.79%3.31%3.22%3.23%3.30%
Net Income Per EBT
-5.45%70.57%65.10%66.70%57.19%
EBT Per EBIT
37.32%53.16%53.98%53.78%60.20%
Return on Assets (ROA)
-0.14%2.45%2.16%2.36%2.29%
Return on Equity (ROE)
-1.13%18.33%16.18%16.54%15.33%
Return on Capital Employed (ROCE)
10.26%9.91%8.51%8.90%9.28%
Return on Invested Capital (ROIC)
5.31%6.03%5.44%5.88%5.35%
Return on Tangible Assets
-0.21%8.13%7.24%6.94%5.87%
Earnings Yield
-0.63%7.08%5.27%3.85%4.57%
Efficiency Ratios
Receivables Turnover
4.94 6.24 5.79 6.48 6.53
Payables Turnover
6.27 2.39 2.53 2.52 2.25
Inventory Turnover
8.18 2.89 2.63 2.86 2.05
Fixed Asset Turnover
2.54 2.42 2.25 2.18 2.28
Asset Turnover
0.82 0.77 0.74 0.78 0.76
Working Capital Turnover Ratio
-29.55 -60.00 33.65 19.66 29.76
Cash Conversion Cycle
60.31 31.90 57.79 38.93 71.68
Days of Sales Outstanding
73.88 58.45 63.02 56.29 55.88
Days of Inventory Outstanding
44.64 126.44 138.95 127.44 178.22
Days of Payables Outstanding
58.21 152.99 144.18 144.80 162.42
Operating Cycle
118.53 184.89 201.97 183.73 234.10
Cash Flow Ratios
Operating Cash Flow Per Share
8.85 11.37 6.36 9.00 5.41
Free Cash Flow Per Share
1.43 4.62 -0.89 2.67 -0.02
CapEx Per Share
7.43 6.76 7.25 6.33 5.44
Free Cash Flow to Operating Cash Flow
0.16 0.41 -0.14 0.30 >-0.01
Dividend Paid and CapEx Coverage Ratio
1.16 1.66 0.84 1.36 0.99
Capital Expenditure Coverage Ratio
1.19 1.68 0.88 1.42 1.00
Operating Cash Flow Coverage Ratio
0.16 0.21 0.11 0.18 0.13
Operating Cash Flow to Sales Ratio
0.12 0.18 0.10 0.15 0.10
Free Cash Flow Yield
7.45%16.14%-2.51%5.62%-0.07%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-158.66 14.13 18.96 25.94 21.90
Price-to-Sales (P/S) Ratio
0.27 0.45 0.55 0.79 0.66
Price-to-Book (P/B) Ratio
1.79 2.59 3.07 4.29 3.36
Price-to-Free Cash Flow (P/FCF) Ratio
13.42 6.20 -39.83 17.79 -1.42K
Price-to-Operating Cash Flow Ratio
2.16 2.51 5.55 5.28 6.41
Price-to-Earnings Growth (PEG) Ratio
1.50 4.62 2.67 1.64 0.14
Price-to-Fair Value
1.79 2.59 3.07 4.29 3.36
Enterprise Value Multiple
4.92 7.50 8.26 8.39 7.87
Enterprise Value
EV to EBITDA
4.92 7.50 8.26 8.39 7.87
EV to Sales
1.00 1.22 1.40 1.52 1.37
EV to Free Cash Flow
49.59 16.86 -100.80 34.30 -2.93K
EV to Operating Cash Flow
7.99 6.84 14.04 10.17 13.25
Tangible Book Value Per Share
-18.33 -46.79 -48.59 -39.52 -31.25
Shareholders’ Equity Per Share
10.69 11.04 11.51 11.07 10.34
Tax and Other Ratios
Effective Tax Rate
0.43 0.26 0.28 0.29 0.38
Revenue Per Share
71.01 64.00 63.73 60.45 52.28
Net Income Per Share
-0.12 2.02 1.86 1.83 1.58
Tax Burden
-0.05 0.71 0.65 0.67 0.57
Interest Burden
0.38 0.53 0.54 0.69 0.60
Research & Development to Revenue
0.00 <0.01 0.00 0.00 0.00
SG&A to Revenue
0.00 0.00 0.16 0.16 0.17
Stock-Based Compensation to Revenue
0.00 <0.01 <0.01 <0.01 <0.01
Income Quality
8.95 5.62 3.24 4.92 3.41
Currency in EUR
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis